Tags

Type your tag names separated by a space and hit enter

Malignant eyelid tumours in Taiwan.
Eye (Lond). 2003 Mar; 17(2):216-20.E

Abstract

AIMS

To describe the clinical characteristics of patients with eyelid cancers in Taiwan.

METHODS

Between 1980 and 2000, 127 (58 males and 69 females) patients (mean age 62.6; range 10-91 years) with histologically confirmed eyelid cancers were retrospectively evaluated at the National Taiwan University Hospital and Far Eastern Memorial Hospital in Taiwan. Clinical data of all patients were reviewed from medical records. The mean follow-up period was 62.4 months (range 3-240) for 113 patients.

RESULTS

The 127 eyelid cancers included 79 basal cell carcinomas (62.2%), 30 sebaceous gland carcinomas (23.6%), 11 squamous cell carcinomas (8.7%), five malignant melanomas (3.9%), one Kaposi's sarcoma (0.8%), and one metastatic cancer (0.8%). Tumours developed more commonly in the lower (37.0%) than the upper eyelid (33.9%). The clinical accuracy in predicting eyelid malignancy was 90.5%. Primary treatment modality was mainly surgical excision. The recurrence, metastasis, and mortality rates at 5 years were 15.2, 11.7, and 7.3%, respectively, for all eyelid malignancies. Rates of sebaceous gland carcinoma recurrence, metastasis, and mortality were significantly higher (P<0.05) than those of basal cell carcinoma. The mean interval of recurrence or metastasis after primary treatment was 26.3 months (range 4-112) for all eyelid cancers.

CONCLUSIONS

Although basal cell carcinoma is the most common eyelid cancer in Taiwan, sebaceous gland carcinoma is also common. Of the two, basal cell carcinoma has a better prognosis and sebaceous gland carcinoma has a higher mortality and therefore should be treated much more aggressively. Long-term follow-up is needed after treatment of malignant eyelid tumours.

Authors+Show Affiliations

Department of Ophthamology, Far Eastern Memorial Hospital, Taipei, Taiwan.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

12640409

Citation

Wang, J-K, et al. "Malignant Eyelid Tumours in Taiwan." Eye (London, England), vol. 17, no. 2, 2003, pp. 216-20.
Wang JK, Liao SL, Jou JR, et al. Malignant eyelid tumours in Taiwan. Eye (Lond). 2003;17(2):216-20.
Wang, J. K., Liao, S. L., Jou, J. R., Lai, P. C., Kao, S. C., Hou, P. K., & Chen, M. S. (2003). Malignant eyelid tumours in Taiwan. Eye (London, England), 17(2), 216-20.
Wang JK, et al. Malignant Eyelid Tumours in Taiwan. Eye (Lond). 2003;17(2):216-20. PubMed PMID: 12640409.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Malignant eyelid tumours in Taiwan. AU - Wang,J-K, AU - Liao,S-L, AU - Jou,J-R, AU - Lai,P-C, AU - Kao,S C S, AU - Hou,P-K, AU - Chen,M-S, PY - 2003/3/18/pubmed PY - 2003/5/16/medline PY - 2003/3/18/entrez SP - 216 EP - 20 JF - Eye (London, England) JO - Eye (Lond) VL - 17 IS - 2 N2 - AIMS: To describe the clinical characteristics of patients with eyelid cancers in Taiwan. METHODS: Between 1980 and 2000, 127 (58 males and 69 females) patients (mean age 62.6; range 10-91 years) with histologically confirmed eyelid cancers were retrospectively evaluated at the National Taiwan University Hospital and Far Eastern Memorial Hospital in Taiwan. Clinical data of all patients were reviewed from medical records. The mean follow-up period was 62.4 months (range 3-240) for 113 patients. RESULTS: The 127 eyelid cancers included 79 basal cell carcinomas (62.2%), 30 sebaceous gland carcinomas (23.6%), 11 squamous cell carcinomas (8.7%), five malignant melanomas (3.9%), one Kaposi's sarcoma (0.8%), and one metastatic cancer (0.8%). Tumours developed more commonly in the lower (37.0%) than the upper eyelid (33.9%). The clinical accuracy in predicting eyelid malignancy was 90.5%. Primary treatment modality was mainly surgical excision. The recurrence, metastasis, and mortality rates at 5 years were 15.2, 11.7, and 7.3%, respectively, for all eyelid malignancies. Rates of sebaceous gland carcinoma recurrence, metastasis, and mortality were significantly higher (P<0.05) than those of basal cell carcinoma. The mean interval of recurrence or metastasis after primary treatment was 26.3 months (range 4-112) for all eyelid cancers. CONCLUSIONS: Although basal cell carcinoma is the most common eyelid cancer in Taiwan, sebaceous gland carcinoma is also common. Of the two, basal cell carcinoma has a better prognosis and sebaceous gland carcinoma has a higher mortality and therefore should be treated much more aggressively. Long-term follow-up is needed after treatment of malignant eyelid tumours. SN - 0950-222X UR - https://www.unboundmedicine.com/medline/citation/12640409/Malignant_eyelid_tumours_in_Taiwan_ L2 - https://doi.org/10.1038/sj.eye.6700231 DB - PRIME DP - Unbound Medicine ER -